STDs at record high, indicating urgent need for prevention – APhA submits compounding comments to FDA.

2501_GraphicImage_061915-piAlabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

STDs at record high, indicating urgent need for prevention – APhA submits compounding comments to FDA. – (866) 348-2889

Last year, more than 2 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States, CDC said Tuesday. Approximately 1.6 million of the new diagnoses were cases of chlamydia, according to CDC’s annual report on STDs. In addition, there were 470,000 cases of gonorrhea and nearly 28,000 cases of primary and secondary syphilis. “Increases in STDs are a clear warning of a growing threat,” noted Jonathan Mermin, MD, MPH, director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. “STDs are a persistent enemy, growing in number, and outpacing our ability to respond.” The report found that rates of syphilis increased by nearly 18% from 2015 to 2016. Most of the cases were among MSM, but there was also a 36% increase in syphilis among women and a 28% increase in congenital syphilis during this period. Rates of gonorrhea increased for both men and women last year. However, the sharpest increase was seen among men, at 22%. To help stem the spread of these diseases, CDC said that renewed commitment is needed from all players.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

STEADI as they go: Pharmacists called upon to help older adults prevent falls – Drug for nerve pain boosts high for opioid abusers.

1Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

STEADI as they go: Pharmacists called upon to help older adults prevent falls – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Falls can be lethal for older adults. Each year one in four Americans aged 65 years and older falls, and every 19 minutes a senior dies from injuries sustained in a fall.

Pharmacists who wish to help older adults—defined as those aged 65 years and older—stay on their feet can find training through STEADI: The Pharmacists Role in Older Adult Fall Prevention, a free online CPE course launched by APhA and CDC last March. The course, which is worth one credit, was created through a partnership between APhA and CDC.

“Pharmacists can make a huge impact preventing falls, so APhA was excited to partner with CDC’s Division of Unintentional Injury Prevention on the creation and accreditation of the STEADI training program. We worked together to identify experts in the field, outline the program, develop content, and bring the training to life,” said Lindsay Kunkle, PharmD, APhA director of practice and science affairs.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Industry pushes back against efforts to control drug prices – APhA submits compounding comments to FDA.

3Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Industry pushes back against efforts to control drug prices – APhA submits compounding comments to FDA. – (866) 348-2889

Despite calls for controlling expensive drug costs coming from all sides of the political spectrum, any momentum to address the issue has been lost amid rancorous debates over replacing the Affordable Care Act and stalled by roadblocks erected via industry pushback. More than two dozen bills aimed at curbing drug prices have been introduced in this or the previous Congress, according to the Drug Pricing Lab, a Memorial Sloan Kettering Cancer Center program that has catalogued ideas for reducing prices. Proposals include importation from other developed countries, where regulations keep prices down; allowing government to negotiate the price of Medicare-covered drugs; speeding approval of cheaper generics; requiring notification before raising drug prices; and restricting consumer drug ads. The Pharmaceutical Research and Manufacturers of America (PhRMA) increased member dues by one-half last year to prepare for battle. The pharmaceutical and health products industries spent $145 million on lobbying for the first half of 2017, according to data from the Center for Responsive Politics. Drugmakers say that high prices reflect heavy investment in innovation and drug development, and reject the notion that the industry wields too much influence in Washington.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

HHS Commits Additional Funding for Opioid Crisis – Drug for nerve pain boosts high for opioid abusers.

4Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

HHS Commits Additional Funding for Opioid Crisis – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

In support of President Donald Trump’s commitment to combat the opioid crisis, HHS has awarded an additional $144.1 million in grants to prevent and treat opioid addiction. Administered by the Substance Abuse and Mental Health Services Administration, the funding will be issued through six grant programs listed in the HHS news release.

The funding will be distributed to 58 recipients, including states, cities, health care providers, and community organizations. The funds will be awarded for three to five years (subject to availability and depending on the program). These awards follow a separate award of $485 million in grants in April 2017 to all 50 states, the District of Columbia, four US territories, and the free associated states of Palau and Micronesia.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

CVS to Limit Opioid Prescriptions to a Seven-Day Supply to Address Opioid Crisis – APhA submits compounding comments to FDA.

29960_pharmacyboard_standard_081816Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

CVS to Limit Opioid Prescriptions to a Seven-Day Supply to Address Opioid Crisis – APhA submits compounding comments to FDA. – (866) 348-2889

In an effort to address the nation’s opioid abuse epidemic, CVS will become the first retail chain pharmacy to limit opioid prescriptions to a seven-day supply for certain conditions. Under its new initiative, CVS will be:

  • Limiting the supply of opioids dispensed to seven days for certain acute prescriptions for patients who are new to therapy;
  • Limiting the daily dosage of opioids dispensed based on the strength of the opioid; and
  • Requiring the use of immediate-release formulations of opioids before extended-release opioids are dispensed.

Additionally, CVS Pharmacy locations will strengthen counseling and educate patients about the Centers for Disease Control and PreventionGuideline for Prescribing Opioids for Chronic Pain, which advises using the lowest effective dose for the shortest duration possible. For patients filling an opioid prescription, pharmacists will counsel patients about the risk of dependence and addiction tied to duration of opioid use, the importance of keeping medications secure in the home, and methods of proper disposal of unused medication.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Tri-Regulator Collaborative Release Position Statements Addressing Electronic Health Records, Practitioner Burnout – Drug for nerve pain boosts high for opioid abusers.

16321_pharmacyboard_standard_080416Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Tri-Regulator Collaborative Release Position Statements Addressing Electronic Health Records, Practitioner Burnout – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

The Tri-Regulator Collaborative, the governing boards of the three organizations representing the state boards that license physicians, pharmacists, and nurses – the Federation of State Medical Boards (FSMB), NABP, and National Council of State Boards of Nursing (NCSBN) – have drafted and approved two position statements that highlight the organizations’ shared commitment to protecting public health as well as the common issues faced by the three groups.

The “ Tri-Regulator Collaborative Position Statement on Electronic Health Records” (EHRs) calls for improving interoperability and uniformity of use, declaring that the seamless transfer of this data is essential to the delivery of high-quality health care and to patient safety. The multiple systems that comprise today’s health care network provide little or no interoperability and present serious concerns for practitioners and regulators. The Collaborative is urging that steps be taken by all stakeholders to bring uniformity and interoperability to EHRs across all practice settings.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Industry pushes back against efforts to control drug prices – APhA submits compounding comments to FDA.

16511-pharmacy-board-standard-041216Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Industry pushes back against efforts to control drug prices – APhA submits compounding comments to FDA. – (866) 348-2889

Despite calls for controlling expensive drug costs coming from all sides of the political spectrum, any momentum to address the issue has been lost amid rancorous debates over replacing the Affordable Care Act and stalled by roadblocks erected via industry pushback. More than two dozen bills aimed at curbing drug prices have been introduced in this or the previous Congress, according to the Drug Pricing Lab, a Memorial Sloan Kettering Cancer Center program that has catalogued ideas for reducing prices. Proposals include importation from other developed countries, where regulations keep prices down; allowing government to negotiate the price of Medicare-covered drugs; speeding approval of cheaper generics; requiring notification before raising drug prices; and restricting consumer drug ads. The Pharmaceutical Research and Manufacturers of America (PhRMA) increased member dues by one-half last year to prepare for battle. The pharmaceutical and health products industries spent $145 million on lobbying for the first half of 2017, according to data from the Center for Responsive Politics. Drugmakers say that high prices reflect heavy investment in innovation and drug development, and reject the notion that the industry wields too much influence in Washington.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Genentech Recalls Three Lots of Activase Due to Lack of Sterility Assurance of the Sterile Water for Injection – Drug for nerve pain boosts high for opioid abusers.

5Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Genentech Recalls Three Lots of Activase Due to Lack of Sterility Assurance of the Sterile Water for Injection – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Genentech, a member of the Roche Group, is voluntarily recalling three lots of Activase® (alteplase) 100 mg vials that were co-packaged with sterile water for injection and distributed to hospitals nationwide. The vials of sterile water for injection, manufactured by Hospira, Inc, and packaged with Activase 100 mg, may be cracked or chipped at the neck of the vial and leaking. Each 100 mg Activase vial (58 million IU) is packaged with diluent for reconstitution (100 mL sterile water for injection, USP), and one transfer device. The National Drug Code is 50242-085-27 for the affected lots, which are listed in a press release. To date, Genentech has not received reports of adverse events associated with use of impacted sterile water for injection. Health care providers who have the recalled lots of Activase should stop using the product and return it to Genentech. Adverse reactions or quality problems experienced with the use of this product may be reported to FDA’s MedWatch Adverse Event Reporting Program.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Sioux Falls PDAC Open to South Dakota Pharmacists – APhA submits compounding comments to FDA.

26799_graphic_standard_080816Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Sioux Falls PDAC Open to South Dakota Pharmacists – APhA submits compounding comments to FDA. – (866) 348-2889

DEA invites South Dakota pharmacists to participate in the upcoming Pharmacy Diversion Awareness Conference (PDAC) in Sioux Falls, SD. DEA is offering a regional one-day conference on Sunday, October 1, 2017. The one-day conference is open to pharmacy personnel (pharmacists, pharmacy technicians, or loss-prevention personnel), who are employed by pharmacies or hospitals/clinics that are registered with DEA in South Dakota. The conference is designed to help pharmacy personnel identify and respond to potential diversion activity. Location details, a conference agenda with speakers and Universal Activity Numbers, and a link to the online registration form are available on the DEA website. There is no registration fee for this conference.

DEA PDACs are cosponsored by NABP for continuing pharmacy education (CPE) credit. NABP and the NABP Foundation® are accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of CPE. The ACPE Provider Number is 0205. Upon completion of the one-day, knowledge-based conference and all CPE requirements, pharmacists and pharmacy technicians may be eligible to receive up to seven hours of CPE credit (0.7 CEUs) after submitting a Statement of Credit electronically to NABP.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off

Bronx Pharmacist Pleads Guilty to Illegally Selling Millions of CS Pills Online – Drug for nerve pain boosts high for opioid abusers.

14774_PHARMACY BOARD_072216Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Bronx Pharmacist Pleads Guilty to Illegally Selling Millions of CS Pills Online – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

An 83-year-old pharmacist who operated Malin Pharmacies in Bronx, NY, pled guilty to conspiring to illegally sell over 5 million prescription butalbital pills, a Schedule III controlled substance (CS), to customers who did not have valid prescriptions across the US. The defendant also agreed to forfeit $9 million to the US, which represented his proceeds from the illegal scheme. Customers ordered butalbital pills online by filling out medical questionnaires that typically posed a series of “yes” or “no” questions. Customers paid for the drugs by, among other means, money orders made out to business entities associated with Malin Pharmacies and Maurice Malin. After the orders were placed via the internet, they were sent to pharmacies, including Malin Pharmacies, that dispensed the prescription drugs to customers.

During the investigation, undercover agents made numerous purchases of butalbital online that were fulfilled by Malin Pharmacies. In certain instances, Malin’s name was listed as the fulfilling pharmacist on the butalbital bottles the agents received. In addition, many of the bottles that were bought undercover did not bear the name of any doctor who had prescribed the butalbital.

CLICK HERE FOR CONTINUE READING

Posted in Pharmacist | Tagged , , , | Comments Off